Fluarix Quadrivalent FDA Approval History
Last updated by Judith Stewart, BPharm on Oct 28, 2020.
FDA Approved: Yes (First approved December 14, 2012)
Brand name: Fluarix Quadrivalent
Generic name: influenza virus vaccine, inactivated
Dosage form: Injection
Treatment for: Influenza Prophylaxis
Fluarix Quadrivalent is an inactivated influenza virus vaccine indicated for the prevention of influenza disease in people aged 6 months and older.
Development timeline for Fluarix Quadrivalent
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.